CDNA

Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 86.58 M84.69 M86.68 M100.06 M108.39 M 379.81 M Gross profit 86.58 M84.69 M86.68 M100.06 M108.39 M 379.81 M Operating expenses 2.2 M98.06 M97.8 M100.3 M114.43 M 410.59 M Selling/general/admin expenses 52.08 M45.76 M51.96 M52.88 M59.61 M 210.21 M Research & development 16.52 M18.52 M16.83 M16.77 M19.31 M 71.43 M Operating income 84.38 M-13.37 M-11.12 M-246 K-6.04 M -30.78 M Non-Operating Income, Total 3.49 M3.08 M2.44 M1.91 M2.28 M 9.7 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 3.05 M2.78 M2.36 M2.01 M2.01 M 9.17 M Unusual income/expense 436 K295 K72 K-107 K264 K 524 K Pretax income 87.87 M-10.29 M-8.69 M1.66 M-3.76 M -21.08 M Equity in earnings ————— — Taxes 171 K58 K-117 K-15 K345 K 271 K Non-controlling/minority interest ————— — After tax other income/expense —7 0000-55 K— — Net income before discontinued operations 87.7 M-10.35 M-8.57 M1.68 M-4.11 M -21.35 M Discontinued operations ————— — Net income 87.7 M-10.35 M-8.57 M1.68 M-4.11 M -21.35 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 87.7 M-10.35 M-8.57 M1.68 M-4.11 M -21.35 M Basic earnings per share (Basic EPS) 1.67-0.19-0.160.03-0.08 -0.4 Diluted earnings per share (Diluted EPS) 1.6-0.19-0.160.03-0.08 -0.4 Average basic shares outstanding 52.77 M55.26 M54.3 M52.51 M53.29 M 215.36 M Diluted shares outstanding 56.62 M55.26 M54.3 M53.74 M53.29 M 216.59 M EBITDA 87.74 M-9.77 M-7.4 M3.57 M-2.16 M -15.76 M EBIT 84.38 M-13.37 M-11.12 M-246 K-6.04 M -30.78 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 3.36 M3.6 M3.72 M3.81 M3.88 M 15.02 M